Curaleaf Appoints Tyneeha Rivers As Chief People Officer
May 24, 2022
Drug Manufacturers
-
-
Marijuana Company of America, Inc. Reports Record First Quarter Revenue and Substantial Quarter-over-Quarter Revenue Growth
May 24, 2022
-
22nd Century Group (Nasdaq: XXII) Announces John J. Miller Joins Its Tobacco Business
May 23, 2022
-
22nd Century Group (Nasdaq: XXII) Begins Integration of GVB Biopharma, Creating a Complete, Robust Hemp/Cannabis Platform
May 18, 2022
-
Can B Corp. Reports First Quarter Revenue Growth of 606% to $1.9 Million, the Highest Quarterly Revenue in Company History
May 18, 2022
-
Cosmos Holdings Reports 12.5% Increase in Revenue, 88.9% Increase in Gross Profit and Achieves Profitability for the First Quarter of 2022
May 18, 2022
-
Petros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
May 16, 2022
-
Endexx Announces Fiscal Second Quarter 2022
May 16, 2022
-
22nd Century Group (Nasdaq: XXII) Acquires GVB Biopharma, a Leading Hemp/Cannabis Company
May 13, 2022
-
CURE Pharmaceutical Announces Positive Findings from Study at Cincinnati Children’s Hospital Medical Center (CCHMC) Using CURE’s Proprietary, Oral Thin Film (OTF) High, Single Dose Vitamin D in Pediatric Patients Pre- and Post-Hematopoietic Stem Cell Transplantation (HSCT)
May 12, 2022
-
Panacea Life Sciences Adds Vegan Softgel Manufacturing Capabilities to Meet the Growing Demand for Clean, Natural Alternatives to Animal Derivatives
May 12, 2022
-
ECOX Spruce Construction Secures License to Launch Green Infrastructure Operations
May 10, 2022
-
Curaleaf Names Matt Darin CEO
May 9, 2022
-
Curaleaf Reports First Quarter 2022 Results
May 9, 2022
-
Curaleaf Expands Retail Presence in Florida with Three New Dispensaries
May 6, 2022
-
Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon Canada
May 5, 2022